TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP

Institutional investor · Portfolio as of Q1 2025

SEC EDGAR SourceSEC Filings

Top Holdings3,162 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

1.5M$836.1M1.8%$509.77+8.06%
26 qtrssince 2018-Q4
Increased
81
XLKXLK
ETF

TECHNOLOGY SELECT SECTOR FUND SPDR

2.1M$431.3M0.9%$107.72-4.64%
12 qtrssince 2022-Q2
Increased
64
QQQQQQ
Unit

INVESCO QQQ TRUST SERIES 1 CL USD INC

907,645$425.6M0.9%$394.59+18.42%
25 qtrssince 2019-Q1
Increased
53
VUGVUG
ETF

VANGUARD GROWTH ETF

1M$378.6M0.8%$59.44+3.42%
8 qtrssince 2023-Q2
Increased
51
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

1M$375.8M0.8%$83.66+7.40%
8 qtrssince 2023-Q2
Increased
48
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

559,000$314.1M0.7%$517.62+6.79%
8 qtrssince 2023-Q2
Decreased
0

CME GROUP INC

1M$270.2M0.6%$175.97+44.45%
26 qtrssince 2018-Q4
Decreased
0

BROADCOM INC

1.6M$261.1M0.6%$165.92-0.06%
7 qtrssince 2023-Q3
Increased
70

SALESFORCE.COM INC

965,724$259.2M0.6%$272.55-2.67%
4 qtrssince 2024-Q2
Increased
70

LOCKHEED MARTIN CORP

567,939$253.7M0.5%$407.07+6.13%
26 qtrssince 2018-Q4
Increased
51

NVIDIA CORP

2.3M$252.9M0.5%$115.99-5.47%
9 qtrssince 2023-Q1
Increased
54

CHENIERE ENERGY INC

1.1M$247.8M0.5%$182.25+25.20%
14 qtrssince 2021-Q4
Decreased
0

BOSTON SCIENTIFIC CORP

2.4M$246.2M0.5%$93.14+8.31%
18 qtrssince 2020-Q4
Increased
70

ALPHABET INC-CL A

1.6M$245.8M0.5%$161.42-4.66%
11 qtrssince 2022-Q3
Increased
50

MARVELL TECHNOLOGY INC

3.9M$242.1M0.5%$72.54-14.77%
3 qtrssince 2024-Q3
Increased
70

SNOWFLAKE INC-CLASS A

1.6M$240.9M0.5%$147.41+2.18%
12 qtrssince 2022-Q2
Increased
50

AMERISOURCEBERGEN CORP

858,612$238.8M0.5%$213.16+28.19%
8 qtrssince 2023-Q2
Increased
49

MSCI INC

421,649$238.4M0.5%$511.06+8.40%
14 qtrssince 2021-Q4
Increased
63

PALANTIR TECHNOLOGIES INC-A

2.8M$237.7M0.5%$85.22+0.74%
12 qtrssince 2022-Q2
Increased
70

ADOBE INC

619,538$237.6M0.5%$453.10-15.35%
13 qtrssince 2022-Q1
Increased
57
$46.8B
AUM
3,162
Positions
Q1 2025
Filing
Rating · 2.5
Quarterly Portfolio Change
+16%Q4'23$41.4B-1%Q1'24$40.8B+3%Q2'24$42.2B+5%Q3'24$44.2B-2%Q4'24$43.5B+6%Q1'25$46B
Activity profile
$ moved · Q1'25
New10%Increased42%Decreased42%Exited6%
Composition
Equity vs derivatives
Equity98%Puts2%Calls0%
Holding period
Avg 4.3 years
<1Q5%1-4Q8%1-2Y8%2Y+79%

TWO SIGMA INVESTMENTS, LP manages $46.8B across 3162 positions as of Q1 2025. Top holdings: SPY (1.8%), XLK (0.9%), QQQ (0.9%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q1 2025 Summary

Active quarter - 471 new positions, 467 exits, 1231 increased. Top move: SPY (INCREASED, conviction 81). Portfolio: $46.8B across 3162 positions.

Top holdings by portfolio weight

Total AUM$46B
SPY1.79%
XLK0.92%
QQQ0.91%
VUG0.81%
IWF0.80%
IVV0.67%
CME0.58%
AVGO0.56%
CRM0.55%
LMT0.54%
Other0.54%

Portfolio allocation by GICS sector

Sectors11
Technology18.61%
Unknown15.35%
Healthcare13.88%
Financial Services10.93%
Industrials10.31%
Consumer Cyclical8.97%
Energy4.74%
Basic Materials4.46%
Communication Services4.20%
Consumer Defensive3.81%
Other4.74%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Unknown, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record51
Conviction38
Concentration12
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AMTBAMTBAMERANT BANCORP INC
Q3 2024 Q2 2026+666,888 shares+$17.1M
8Q
ARCTARCTARCTURUS THERAPEUTICS HLDGS
Q3 2024 Q2 2026+1.1M shares+$7M
8Q
BCRXBCRXBIOCRYST PHARMACEUTICALS INC
Q3 2024 Q2 2026+5.1M shares+$57.4M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used